Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protagonist Therapeutics (PTGX) Tax Provisions: 2018-2025

Historic Tax Provisions for Protagonist Therapeutics (PTGX) over the last 2 years, with Jun 2025 value amounting to $200,000.

  • Protagonist Therapeutics' Tax Provisions rose 128.57% to $200,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $1.1 million, marking a year-over-year decrease of 72.95%. This contributed to the annual value of $4.2 million for FY2024, which is N/A change from last year.
  • Per Protagonist Therapeutics' latest filing, its Tax Provisions stood at $200,000 for Q2 2025, which was down 89.95% from $2.0 million recorded in Q4 2024.
  • Protagonist Therapeutics' Tax Provisions' 5-year high stood at $3.3 million during Q1 2024, with a 5-year trough of -$700,000 in Q2 2024.
  • For the 2-year period, Protagonist Therapeutics' Tax Provisions averaged around $879,200, with its median value being $200,000 (2025).
  • Data for Protagonist Therapeutics' Tax Provisions shows a peak YoY surged of 128.57% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Protagonist Therapeutics' Tax Provisions stood at $2.0 million in 2024, then soared by 128.57% to $200,000 in 2025.
  • Its Tax Provisions was $200,000 in Q2 2025, compared to $2.0 million in Q4 2024 and -$420,000 in Q3 2024.